BOLD - Audentes Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - BOLD (1628738)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
29 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P1+0-2+0+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2018-07-02
BOLDPrasad SuyashSVP, Chief Med OfficerS - Sale+OE$38.41-10,0005,011-67%-$384,067
DM
2018-07-02
BOLDPatterson Matthew RCEOS - Sale+OE$39.55-71,048171,814-29%-$2,809,837
D
2018-06-25
BOLDNewman MarySVP, Regulatory AffairsS - Sale+OE$40.79-8,5450-100%-$348,581
2018-06-25
BOLDLange Louis GDirS - Sale$40.59-33,000471,591-7%-$1,339,498
D
2018-06-20
BOLDNagler DavidSVP, HR, Corp. AffairsS - Sale+OE$45.29-5,0000-100%-$226,461
D
2018-05-21
BOLDPatterson Matthew RPres, CEOS - Sale+OE$38.15-20,300171,814-11%-$774,498
D
2018-04-02
BOLDPatterson Matthew RPres, CEOS - Sale+OE$30.01-700171,8140%-$21,009
D
2018-03-15
BOLDNewman MarySVP, Regulatory AffairsS - Sale+OE$30.36-10,0000-100%-$303,627
D
2017-03-29
BOLDPrasad SuyashSVP, Chief Med OfficerS - Sale+OE$30.02-7,8000-100%-$234,195
DM
2018-03-26
BOLDPrasad SuyashSVP, Chief Med OfficerS - Sale+OE$30.00-2,2000-100%-$66,000
2018-03-26
BOLDLange Louis GDirS - Sale$28.89-48,000505,974-9%-$1,386,937
M
2018-03-08
BOLDOrbimed Advisors LLC10%S - Sale$34.97-156,4313,539,997-4%-$5,469,926
M
2018-03-02
BOLDOrbimed Advisors LLC10%S - Sale$35.11-433,2103,696,428-10%-$15,210,616
2017-12-22
BOLDLange Louis GDirS - Sale$30.88-18,000549,933-3%-$555,792
D
2017-12-01
BOLDPrasad SuyashSVP, Chief Med OfficerS - Sale+OE$28.53-8,0000-100%-$228,264
D
2017-11-16
BOLDNewman MarySVP, Regulatory AffairsS - Sale+OE$26.84-10,0000-100%-$268,375
D
2017-10-02
BOLDPatterson Matthew RPres, CEOS - Sale+OE$27.92-25,000171,814-13%-$698,070
2017-09-29
BOLDOrbimed Advisors LLC10%S - Sale$28.25-672,0004,129,638-14%-$18,984,000
D
2017-09-27
BOLDNagler DavidSVP, HR, Corp. AffairsS - Sale+OE$30.00-3,7500-100%-$112,500
2017-09-29
BOLDLange Louis GDirS - Sale$28.35-11,000573,691-2%-$311,903
2017-09-25
BOLDLange Louis GDirS - Sale$28.32-18,000586,850-3%-$509,727
DM
2017-09-15
BOLDPatterson Matthew RPres, CEOS - Sale+OE$25.06-10,000186,814-5%-$250,561
D
2017-09-15
BOLDNagler DavidSVP, HR, Corp. AffairsS - Sale+OE$25.00-3,7500-100%-$93,750
D
2017-09-07
BOLDOrbimed Advisors LLC10%S - Sale+OE$22.35-5,0004,801,6380%-$111,750
D
2017-09-01
BOLDPrasad SuyashSVP, Chief Med OfficerS - Sale+OE$21.44-8,0000-100%-$171,481
D
2017-08-24
BOLDNewman MarySVP, Regulatory AffairsS - Sale+OE$20.00-10,0000-100%-$200,000
M
2017-07-12
BOLDPatterson Matthew RPres, CEOS - Sale$20.00-15,000186,814-7%-$300,059
2017-06-26
BOLDLange Louis GDirS - Sale$19.78-15,000596,933-2%-$296,682
2017-04-24
BOLD5Am Partners Iii, LLCformer 10% ownerP - Purchase$14.50+172,4132,564,544+7%+$2,499,9890-2

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top